Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 12Active not recruiting 8Not yet recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 152Neoplasms 108Carcinoma, Non-Small-Cell Lung 83Colorectal Neoplasms 81Prostatic Neoplasms 80Lung Neoplasms 71Leukemia, Myeloid, Acute 48Carcinoma, Hepatocellular 48Pancreatic Neoplasms 45Neoplasm Metastasis 39Multiple Myeloma 37Recurrence 34Triple Negative Breast Neoplasms 29Squamous Cell Carcinoma of Head and Neck 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Melanoma 27Glioblastoma 27Head and Neck Neoplasms 25Brain Neoplasms 25Uterine Cervical Neoplasms 24Stomach Neoplasms 24Rectal Neoplasms 24Ovarian Neoplasms 24Small Cell Lung Carcinoma 22Carcinoma, Renal Cell 20Lymphoma, B-Cell 19Lymphoma, Follicular 18Lymphoma 18Endometrial Neoplasms 18Glioma 17

Interventions

alovudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Metastatic Castration-resistant Prostate Cancer × 90 days × Clear all
NCT07608718 2026-05-27

Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting
19 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT07609225 2026-05-27

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

University of Wisconsin, Madison

Phase EARLY_PHASE1 Not yet recruiting
15 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡